ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Intersection of Immunology & Rheumatology

Mary Beth Nierengarten  |  November 5, 2025

The turning point in looking beyond a diagnosis of seronegative inflammatory arthritis came when Dr. Anwardeen and his colleagues broadened their perspective beyond joints and inflammation, considering the patient’s immune function. Further testing confirmed X-linked Agammaglobulinemia, or Bruton’s disease, which showed a primary antibody deficiency that explained the patient’s infections and arthritis.

The finding changed the management approach from immune suppression to immune replacement, and the patient was started on intravenous immunoglobulin (IVIG) therapy. Cardiothoracic specialists were included to monitor his porcelain aorta.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

This management approach resulted in ending the infections and needing only minimal therapy to control the patient’s arthritis.

Key Points

Dr. Anwardeen

“I chose this case because it highlights the intersection between immunology and rheumatology,” Dr. Anwardeen said. “It was not a story of immune excess, but of immune silence [in which] the absence of defense led to inflammation.”

The case reminded him that behind every atypical presentation lies a story waiting to be uncovered.

The take-home message of this case experience was that not all inflammation is caused by immune overactivity. Sometimes, it results from immune absence. Dr. Anwardeen urged clinicians to consider primary immunodeficiency as part of a diagnostic differential in patients with recurrent infections and unexplained arthritis.

He also urged clinicians to consider causes of porcelain aorta because it includes inflammation and chronic infection, as well as hereditary causes.

Explaining the title of his case, Dr. Anwardeen said the silent guard represents the patient’s absent antibody defense, and the ceramic core symbolizes the calcified aorta, calling it a silent scar of chronic inflammation.

“Ultimately, this case reminds us that medicine is not only about the immune system’s actions, but also about its silences and the lasting stories they leave behind,” he said.

Acknowledgements

Dr. Bin Anwardeen emphasized the collective team effort in making the differential diagnosis and change in subsequent treatment strategy for this patient. He specifically expressed gratitude to his consultants and mentors, Dr. Liza Mohd Isa, Dr. Nor Shuhaila Shahril and Dr. Azwarina Hanim Ramlan, for their wisdom, encouragement and constant guidance in shaping every part of the journey of the initial presentation of the patient to the ultimate diagnosis and treatment.

“Their mentorship, along with the support of my colleagues, made it possible to explore this rare case and bring Malaysia’s perspective to an international platform,” he said.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting Reports Tagged with:ACR Convergence 2025Bruton’s diseaseX-linked Agammaglobulinemia

Related Articles

    Rheumatologists Across Borders

    July 8, 2025

    The EULAR/ACR/APLAR Research Exchange Program is an opportunity to learn and exchange ideas within the rheumatology community internationally. Here the program’s most recent participants share their experiences & excitement.

    The 2018 ACR/ARHP Annual Meeting Program Preview

    September 20, 2018

    Save the date for the 2018 ACR/ARHP Annual Meeting, Oct. 19–24 in Chicago. Connect with your colleagues for an unmatched educational experience featuring exceptional sessions by leading rheumatology experts. The ACR/ARHP Annual Meeting is your gateway to global rheumatology education. With more than 450 sessions—including The Great Debate—the meeting provides boundless opportunities for professional development,…

    Imaging in Ankylosing Spondylitis

    April 1, 2015

    MRI inflammation, fat and new bone formation in the sacroiliac joints, spine in patients with AS

    Updates on Giant Cell Arteritis

    March 19, 2018

    SAN DIEGO—Recent research tells us more about giant cell arteritis (GCA) to help rheumatologists more accurately diagnose and effectively treat patients with this type of vasculitis. On Nov. 6 at the ACR/ARHP Annual Meeting, three experts explored the latest findings on GCA pathogenesis, diagnostic approaches, imaging modalities and growing treatment options. GCA: What’s Really Happening?…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences